Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 260
7
Diseases
7
Unique genes
0.282
Avg. similarity score
Cerebellar ataxia, impaired intellectual development, and dysequilibrium
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Cerebellar ataxia, impaired intellectual development, and dysequilibrium
Cerebellar ataxia, intellectual disability, and dysequilibrium
Dysequilibrium syndrome
Cerebellar hypoplasia
cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1
Cerebellar ataxia, intellectual disability, oculomotor apraxia, cerebellar cysts
Cerebellar ataxia, mental retardation, and dysequilibrium
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cerebellar ataxia, impaired intellectual development, and dysequilibrium | 6 | 6 | 3 |
| Cerebellar ataxia, intellectual disability, and dysequilibrium | 6 | 6 | 6 |
| Dysequilibrium syndrome | 6 | 6 | 6 |
| Cerebellar hypoplasia | 4 | 4 | 1 |
| cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 | 4 | 4 | 1 |
| Cerebellar ataxia, intellectual disability, oculomotor apraxia, cerebellar cysts | 3 | 3 | 2 |
| Cerebellar ataxia, mental retardation, and dysequilibrium | 3 | 3 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| VLDLR | 5 / 7 | Cerebellar ataxia, impaired intellectual development, and dysequilibrium, Cerebellar ataxia, intellectual disability, and dysequilibrium, cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1, Cerebellar hypoplasia and 1 more |
| ATP8A2 | 4 / 7 | Cerebellar ataxia, impaired intellectual development, and dysequilibrium, Cerebellar ataxia, intellectual disability, and dysequilibrium, Cerebellar ataxia, intellectual disability, oculomotor apraxia, cerebellar cysts, Dysequilibrium syndrome |
| WDR81 | 4 / 7 | Cerebellar ataxia, impaired intellectual development, and dysequilibrium, Cerebellar ataxia, intellectual disability, and dysequilibrium, Cerebellar ataxia, mental retardation, and dysequilibrium, Dysequilibrium syndrome |
| CA8 | 3 / 7 | Cerebellar ataxia, intellectual disability, and dysequilibrium, Cerebellar ataxia, mental retardation, and dysequilibrium, Dysequilibrium syndrome |
| RIPPLY1 | 2 / 7 | Cerebellar ataxia, intellectual disability, and dysequilibrium, Dysequilibrium syndrome |
| TUBB2B | 2 / 7 | Cerebellar ataxia, intellectual disability, and dysequilibrium, Dysequilibrium syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Reelin signalling pathway | Reactome | 1 / 5 | 343× | 2.91e-3 | 3.01e-2 ✓ sig. |
| VLDL clearance | Reactome | 1 / 5 | 343× | 2.91e-3 | 3.01e-2 ✓ sig. |
| VLDLR internalisation and degradation | Reactome | 1 / 12 | 143× | 6.97e-3 | 5.45e-2 |
| Nitrogen metabolism | KEGG | 1 / 17 | 101× | 9.87e-3 | 6.81e-2 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | Reactome | 1 / 18 | 95.3× | 1.04e-2 | 7.05e-2 |
| Cilium Assembly | Reactome | 1 / 19 | 90.3× | 1.10e-2 | 7.27e-2 |
| Carboxyterminal post-translational modifications of tubulin | Reactome | 1 / 27 | 63.5× | 1.56e-2 | 8.93e-2 |
| Laminin interactions | Reactome | 1 / 28 | 61.3× | 1.62e-2 | 9.12e-2 |
| MET activates PTK2 signaling | Reactome | 1 / 30 | 57.2× | 1.74e-2 | 9.50e-2 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | Reactome | 1 / 31 | 55.3× | 1.79e-2 | 9.70e-2 |
| RHO GTPases activate IQGAPs | Reactome | 1 / 32 | 53.6× | 1.85e-2 | 9.85e-2 |
| Aggrephagy | Reactome | 1 / 40 | 42.9× | 2.31e-2 | 1.12e-1 |
| Recycling pathway of L1 | Reactome | 1 / 40 | 42.9× | 2.31e-2 | 1.12e-1 |
| COPI-independent Golgi-to-ER retrograde traffic | Reactome | 1 / 51 | 33.6× | 2.94e-2 | 1.27e-1 |
| Intraflagellar transport | Reactome | 1 / 54 | 31.8× | 3.11e-2 | 1.31e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| involuntary skeletal muscle contraction | GO:0003011 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| positive regulation of axon guidance | GO:1902669 | 1 / 2 | 1,335× | 7.49e-4 | 1.25e-2 ✓ sig. |
| glycoprotein transport | GO:0034436 | 1 / 3 | 890× | 1.12e-3 | 1.62e-2 ✓ sig. |
| positive regulation of phospholipid translocation | GO:0061092 | 1 / 4 | 667× | 1.50e-3 | 1.91e-2 ✓ sig. |
| very-low-density lipoprotein particle clearance | GO:0034447 | 1 / 5 | 534× | 1.87e-3 | 2.19e-2 ✓ sig. |
| somite specification | GO:0001757 | 1 / 5 | 534× | 1.87e-3 | 2.19e-2 ✓ sig. |
| lipid transport | GO:0006869 | 2 / 189 | 28.2× | 2.07e-3 | 2.30e-2 ✓ sig. |
| retinal blood vessel morphogenesis | GO:0061304 | 1 / 6 | 445× | 2.25e-3 | 2.41e-2 ✓ sig. |
| regulation of basement membrane organization | GO:0110011 | 1 / 6 | 445× | 2.25e-3 | 2.41e-2 ✓ sig. |
| aminophospholipid translocation | GO:0140331 | 1 / 7 | 381× | 2.62e-3 | 2.62e-2 ✓ sig. |
| ventral spinal cord development | GO:0021517 | 1 / 9 | 297× | 3.37e-3 | 3.01e-2 ✓ sig. |
| neurofilament cytoskeleton organization | GO:0060052 | 1 / 10 | 267× | 3.74e-3 | 3.18e-2 ✓ sig. |
| morphogenesis of an epithelial sheet | GO:0002011 | 1 / 10 | 267× | 3.74e-3 | 3.18e-2 ✓ sig. |
| somite rostral/caudal axis specification | GO:0032525 | 1 / 11 | 243× | 4.11e-3 | 3.32e-2 ✓ sig. |
| branching involved in salivary gland morphogenesis | GO:0060445 | 1 / 12 | 222× | 4.49e-3 | 3.47e-2 ✓ sig. |